Maxine D. Fisher, PhD, joins Vector Oncology as Director of
Real World Evidence
Vector Oncology is pleased to announce that Maxine Fisher, PhD, has joined our Health Economics and Outcomes Research team as Director of Real World Evidence. With over 10 years of real world analytics expertise, Maxine is a valuable addition to our staff of doctoral level scientists, one of the most experienced teams in real world oncology research today. As Director of Real World Evidence, her role will include design of new processes for conduct of real world research at Vector Oncology, and direct scientific oversight of health outcomes studies. “Maxine is a proven leader, and will allow us to scale the bandwidth of our scientific team. She has valuable HEOR experience working with real world evidence for over a decade, and is a great addition for Vector Oncology,” said Vector Oncology Chief Operating Officer, Edward Stepanski, PhD.In her previous role as Associate Director of Outcomes Research at HealthCore, Maxine led multi-disciplinary teams to design and deliver real world research for her biopharmaceutical clients. Taking on roles of increasing responsibility over the past decade, her experience includes all aspects of late stage research from developing protocols and statistical analysis plans, medical chart abstraction, data extraction, statistical analysis, medical writing, and oversight of real world research studies.Earlier in her career, Maxine served as Scientific Writer / Intellectual Property Scientist at Sagres Discovery, Medical Writer at the Cancer Information Group, and Postdoctoral Researcher at the University of Texas Southwestern Medical Center. She holds a PhD, Biochemistry and Molecular Biology from University of Florida and a B.S. Chemistry (Certified, American Chemical Society) from University of Miami. Maxine has authored over 27 publications, 13 of which have been published in peer reviewed journals in the past 9 years.

Vector Oncology has over a decade of experience designing and delivering real world research in oncology care. Utilizing our comprehensive Oncology Data Warehouse, our proprietaryPatient Care Monitor (PCM) patient engagement platform, and our experienced study management team, our medical experts and doctoral level scientists design and deliver high-quality projects using real world evidence.

For more information on Vector Oncology services, please contact:

Mahnoush Haririfar
Senior Director, Business Development
[email protected]

view online here –


2017-07-03T20:45:17+00:00 December 5th, 2014|